Clinical Outsourcing Group
At Pharmaceutical Business Conference Group, we believe that the most important part of any conference is its agenda content.
The thought leadership delivered from the stage drives everything else at the event, setting the tone, creating engagement, and providing attendees with actionable insights to improve their roles once the event is finished.
Our expert Advisory Board is drawn from across the global clinical trial landscapes, representing trial sponsors, solution providers, independent consultants, investors, and not-for-profits. As well as making direct contributions to our agendas as speakers themselves, our Advisory Board shape the global message across the Clinical Outsourcing Group Series with unparalleled expertise and collective experience.
Clinical Services International
Vanessa started her career as a research associate at Scotland Yard and then joined LGC Group. Subsequently, she joined IQVIA where she worked with some of the largest biopharmaceuticals and biotechs to provide innovative solutions.
She has extensive experience in drug development from preclinical to registration and commercialisation strategies. She has secured product registration for several orphan and first-in-class drugs. She was also Chief Commercial Officer in a leading technology provider for patient access to clinical trials.
Vanessa was Senior Advisor to DiGamma Capital. She is on the Enterprise Advisory Board of CW+ and undertakes extensive charity work. She has a PhD in Cardiovascular Genetics from UCL, an MBA from Cambridge and a Masters Degree in Market Access from the University of Lyon. She also sits on the advisory board of Cambridge Business School.
Leader in Clinical Research, with more than 30 year’s experience in Corporate R&D pharma organizations , Thierry has been promoting patient engagement strategy across the Industry
Thierry is now acting as an independent consultant providing strategic consulting to pharma/CROs and vendors to provide the best services and products for the benefits of the patient’s community
Thierry is very much convinced that digital innovation and patient engagement are the key success factors in the drug development phase and will impact positively the medicinal product lifecycle.
CEO & Founder - HERhealthEQ
CEO - DeepLook Medical
Partner - Goddess Gaia Ventures
Marissa is a 20+ year medtech executive, innovator, entrepreneur, investor, and philanthropist. She is the CEO and founder of non-profit HERhealthEQ, CEO of DeepLook Medical, VP of Operations at Ultrasound AI, and US Partner at Goddess Gaia Ventures. Her mission is to move innovation and the health of women forward throughout the world. Marissa is a TEDx Speaker (2019 at TEDxLugano), a UCSC Miller Center Social Entrepreneur Fellow, and has been listed as one of the Top 100 Women in Medtech in 2018, a First in FemTech award winner in 2022, and a Top Woman Activist to Watch. Marissa graduated from Boston University with a BS in Manufacturing Engineering and from University of Connecticut with an MBA.
Hexagon Supply Chain
Sue is a Healthcare Supply Chain professional with extensive experience shipping clinical and specialty commercial drug, and clinical samples. With over 30 years of GxP process development and application, she works with companies utilising risk management and logistics planning with her business experience to produce practical solutions that deliver results.
She is passionate about bringing vaccines and medicines to the developing world and ensuring access through safe and successful shipping using creative packaging and monitoring solutions.
In her copious spare time she keeps bees, and runs an accidental embroidery business.
Chief Medical Officer
Dr. Moser is an oncologist who has worked as a clinician and academic researcher for over 20 years and specialized in drug development for the past 10. Her deepest interest lies in strategic clinical trial planning, bridging preclinical proof to cancer patients. She is a strong advocate for innovation to improve global access to affordable care. She served as strategic consultant for various larger and small companies, currently as Chief Medical Officer at Deka Biosciences, she is using her expertise and network to drive fast clinical translation of innovative, more effective, and better tolerated immunotherapies.
Dana is the co-founder and CEO of August Research, a boutique CRO conducting Phase I-IV clinical trials across Europe since 2012. August Research is the third company started by Dana in the drug development space in Europe. In 2000, she co-founded and served as CEO of AbCRO, a small CRO focused on conducting clinical trials in Central and Eastern Europe. AbCRO was acquired by PPD in 2009. At the time of AbCRO’s acquisition, Sofia Bio was spun out of AbCRO and developed as a stand-alone company focused on the acquisition of biospecimen samples for research purposes. Sofia Bio was acquired by Discovery Life Sciences in 2019. She has a B.S. degree from Cornell University and an MBA from The Darden School at the University of Virginia.
Joan Chambers is the CEO of Greater Gift, an independent, non-profit organization whose mission is to increase public understanding and awareness of clinical research and foster trust by celebrating all those engaged in it, including patients, caretakers, healthcare and business professionals, and team members. Over the course of her career, Joan, who has more than 30 years of expertise in the clinical research industry, has implemented a variety of senior leadership strategies and functions within the organizations she has worked for. A seasoned executive with strong leadership abilities in team management, strategic business and financial planning, integrated marketing, communications, and educational initiatives for B2B and B2C audiences—print and digital—with the aim of enhancing audience engagement, fostering partnerships, and establishing scalable and sustainable business growth.